The transforming growth factor-β1 (TGF-β1) signaling pathway is a key initiator and driver of ECM protein deposition and fibrotic disease [43, 44], and excessive TGF-β-mediated signaling promotes PAH development [45]. Here, TGFB1 is linked to pulmonary arterial hypertension.